Posted by Clinical Lab Products | Dec 4, 2003 | Miscellaneous |
By Nicholas Borgert Bio-Rad Laboratories has expanded its TOX/See™ Rapid Urine Drug Screen platform with new capabilities to detect tricyclic antidepressants (TCA) and Ecstasy (MDMA). The new tests have been added to a TOX/See test menu tha
Read MorePosted by Clinical Lab Products | Sep 9, 2003 | Cancer, Miscellaneous |
Beckman Coulter Signs Agreement With Bio-Rad Beckman Coulter Inc has signed an agreement with Bio-Rad Laboratories Inc for the development, manufacture, and distribution of infectious disease and blood virus assays. The agreement will enable Beckm
Read MorePosted by Clinical Lab Products | Jul 9, 2003 | Cancer, Miscellaneous |
Roche launches pharmacogenomic microarray
Read MorePosted by Clinical Lab Products | Jun 9, 2003 | Cancer, Miscellaneous |
PSA test for prostate cancer should be repeated before biopsy The prostate specific antigen (PSA) blood test is used in routine prostate cancer screening for men over 50, and elevated PSA levels typically result in referral for a prostate biopsy.
Read MorePosted by Clinical Lab Products | Mar 3, 2003 | Cancer, Heart Disease, Miscellaneous |
By Coleen Curran hs-CRP may diagnose potential cardiac risk and be the tip of the “inflammatory response” iceberg While heart disease is still the No. 1 killer of humans – male and female – an increasing number of us survive t
Read More